Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation

Lancet. 1986 Oct 25;2(8513):946-9. doi: 10.1016/s0140-6736(86)90601-x.


Hexamethylpropylene-amineoxime (HMPAO) forms a lipid-soluble neutral complex with 99mTc which is rapidly incorporated into leucocytes in vitro. In six patients with suspected or known inflammatory disease, a "mixed" leucocyte suspension isolated from 85 ml blood anticoagulated with acid-citrate-dextrose was labelled by 99mTc-HMPAO with a mean efficiency of 47% (SE2%), of which 78% (3) was taken up by granulocytes. Activity eluted more rapidly from other cell types in vitro than from granulocytes, which remained firmly labelled. Mean initial biodistribution of the label and granulocyte recovery in blood of 32% (8) at 30-40 min showed that the granulocytes were not significantly activated during labelling. All six patients were positive for inflammatory disease, as early as 30 min in five patients and at 3 h in the sixth; they all remained positive at 20-24 h. Four patients also received 111In-labelled "pure" granulocytes. In terms of detail, the 99mTc images were comparable or superior to the 111In images.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Granulocytes*
  • Humans
  • Indium
  • Inflammation / diagnostic imaging
  • Intestinal Diseases / diagnostic imaging*
  • Isotope Labeling / methods
  • Middle Aged
  • Oximes*
  • Radioisotopes
  • Radionuclide Imaging
  • Technetium Tc 99m Exametazime
  • Technetium*


  • Oximes
  • Radioisotopes
  • Indium
  • Technetium Tc 99m Exametazime
  • Technetium